Literature DB >> 15789227

Cytomegalovirus-associated meningoradiculoneuritis after treatment of mantle cell lymphoma with a combination of chemotherapy and rituximab.

S Vallet, A Tempescul, A Tran, M C Legrand-Quillien, V Narbonne, C Berthou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15789227     DOI： 10.1007/s00277-005-1038-0

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

1.  Prolonged reactivation of cytomegalovirus infection following successful rituximab therapy for Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder.

Authors:  Makoto Hirokawa; Yoshinari Kawabata; Naohito Fujishima; Tomoko Yoshioka; Ken-ichi Sawada
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

2.  Infectious complications of immune modulatory agents.

Authors:  Ricardo M La Hoz; John W Baddley
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

Review 3.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 4.  Infections associated with monoclonal antibody and fusion protein therapy in humans.

Authors:  Florence Uettwiller; Emilie Rigal; Cyrille Hoarau
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

Review 5.  Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis.

Authors:  Simone Lanini; Aoife C Molloy; Paul E Fine; Archibald G Prentice; Giuseppe Ippolito; Christopher C Kibbler
Journal:  BMC Med       Date:  2011-04-12       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.